Skip to main content
Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · IEX Real-Time Price · USD
10.90
-0.04 (-0.37%)
At close: Apr 24, 2024, 4:00 PM
11.00
+0.10 (0.92%)
After-hours: Apr 24, 2024, 5:41 PM EDT

Roivant Sciences Income Statement

Millions USD. Fiscal year is Apr - Mar.
Year 2022202120202019
Revenue
61.2855.2923.867.69
Revenue Growth (YoY)
10.84%132.34%-64.85%-
Cost of Revenue
13.138.972.061.13
Gross Profit
48.1546.3221.7466.56
Selling, General & Admin
600.51775.03259.88335.77
Research & Development
622.96622.93832.76263.22
Operating Expenses
1,2231,3981,093598.98
Operating Income
-1,175.32-1,351.64-1,070.9-532.43
Interest Expense / Income
27.977.0400
Other Expense / Income
-199.45-513.79-263.35-1,740.06
Pretax Income
-1,003.84-844.89-807.551,208
Income Tax
5.190.371.697.12
Net Income
-1,009.03-845.26-809.231,201
Shares Outstanding (Basic)
713670630219
Shares Outstanding (Diluted)
713670630219
Shares Change
6.43%6.30%187.64%-
EPS (Basic)
-1.42-1.26-1.285.13
EPS (Diluted)
-1.42-1.26-1.285.13
Free Cash Flow
-856.08-695.17-557.94-763.67
Free Cash Flow Per Share
-1.20-1.04-0.89-3.49
Gross Margin
78.58%83.78%91.36%98.33%
Operating Margin
-1917.95%-2444.82%-4500.52%-786.58%
Profit Margin
-1646.59%-1528.89%-3400.86%1773.57%
Free Cash Flow Margin
-1397.00%-1257.40%-2344.80%-1128.20%
Effective Tax Rate
---0.59%
EBITDA
-949.45-824.65-807.551,208
EBITDA Margin
-1549.36%-1491.61%-3393.77%1784.09%
Depreciation & Amortization
26.4213.200
EBIT
-975.87-837.85-807.551,208
EBIT Margin
-1592.48%-1515.49%-3393.77%1784.09%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).